✦ LIBER ✦

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS

✍ Scribed by Susanna J. Dunachie; Michael Walther; Jenni M. Vuola; Daniel P. Webster; Sheila M. Keating; Tamara Berthoud; Laura Andrews; Philip Bejon; Ian Poulton; Geoffrey Butcher; Katherine Watkins; Robert E. Sinden; Amanda Leach; Philippe Moris; Nadia Tornieporth; Joerg Schneider; Filip Dubovsky; Eveline Tierney; Jack Williams; D. Gray Heppner Jr.; Sarah C. Gilbert; Joe Cohen; Adrian V.S. Hill

Book ID: 116958659
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 228 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2005.12.041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of the RTS,S/A

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

✍ E. Macete; J. J. Aponte; C. Guinovart; J. Sacarlal; O. Ofori-Anyinam; I. Mandoma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 535 KB

Safety and efficacy of the RTS,S/AS01E c

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

✍ Kwaku Poku Asante; Salim Abdulla; Selidji Agnandji; John Lyimo; Johan Vekemans; 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 260 KB

Safety of the RTS,S/AS02D candidate mala

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

✍ John J Aponte; Pedro Aide; Montse Renom; Inacio Mandomando; Quique Bassat; Jahit 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 192 KB

Randomized, controlled trial of the long

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02Dmalaria vaccine in infants living in a malaria-endemic region

✍ Salim Abdulla, Nahya Salim, Francisca Machera, Richard Kamata, Omar Juma… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 243 KB

A phase I/IIa safety, immunogenicity, an

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

✍ Kent E. Kester; Denise A. McKinney; Nadia Tornieporth; Christian F. Ockenhouse; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Phase 2a trial of 0, 1, and 3 month and

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research

✍ Kent E. Kester; James F. Cummings; Christian F. Ockenhouse; Robin Nielsen; B. Te 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 834 KB